抗体研究を加速するためには、高品質な抗体やタンパク質へのアクセス、効率的な生産スケジュール、信頼できるパートナーシップが不可欠です。抗体の探索、発現、最適化を専門とするリーディングCRO（契約研究機関）であるBiointronは、こうしたニーズに応える信頼できる選択肢として、多くの企業に支持されています。

カスタム抗体の開発は、研究および治療革新の推進において重要な要素です。抗体発現サービスを専門とする契約研究機関（CRO）であるBiointronは、抗体生産のニーズに対して信頼性が高く、スケーラブルで高品質なソリューションを求めるバイオテック企業に包括的なサポートを提供します。

We are excited to announce that Biointron will be participating in BIOPLUS-INTERPHEX KOREA 2024, which will take place from July 10 - 12, 2024, at COEX, Seoul, South Korea. This prestigious event is a key gathering for professionals in the biopharmaceutical and biotechnology industries, and we look forward to showcasing our latest advancements and engaging with industry leaders.

We are excited to announce that Biointron will be participating in the Antibody Engineering & Therapeutics US 2024 conference, taking place from December 15 - 18, 2024, at the Marriott Marquis San Diego, California. We are looking forward to showcasing our latest innovations and connecting with industry professionals.

We are pleased to announce that Biointron will be participating in The 3rd Annual Meeting of the Antibody Society of Japan, scheduled for December 9 - 11, 2024, at the Sendai International Center, Japan. This event is a significant gathering for professionals in the antibody research field, and we are excited to share our latest developments and engage with industry leaders.

We are excited to announce that Biointron will be participating in the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024, taking place from November 6-10, 2024, in Houston, Texas. You can find us at booth #515, where we look forward to showcasing our latest innovations and connecting with industry professionals.

We are delighted to announce that Biointron will be participating in PEGS Europe 2024, from November 5 - 7, 2024, at Barcelona, Spain. You can find us at booth #1102, where we look forward to showcasing our latest innovations and engaging with industry professionals.

Biointron will be participating in the Festival of Biologics 2024 - Europe, scheduled for October 15-17, 2024, at the Congress Center Basel in Switzerland. This prestigious event is a key gathering for professionals in the biologics industry, and we are eager to showcase our latest advancements and connect with industry leaders.

We are delighted to announce that Biointron will be attending the Antibody Therapeutics Xchange 2024 Boston, which will take place on June 17, 2024. This exclusive event is a gathering of the leading minds in antibody therapeutics, offering a unique platform for collaboration, innovation, and knowledge sharing.

In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron&#

We are thrilled to announce Biointron's participation in the 20th Annual PEGS Boston (The Protein Engineering Summit), happening from May 13-17, 2024, in Boston, MA. Organized by CHI, this summit is the epitome of innovation in protein and antibody engineering, a field where Biointron has continually demonstrated its leadership.

Biointron invites you to join us at BIO KOREA 2024! Bio Krea has been a premier international convention for biotech companies and industry leaders. Scheduled from May 8th to 10th, 2024, at COEX in Seoul, this event promises to be a nexus of innovation in the health industry.

Biointron is excited to invite you to Biologics 2024, scheduled from 13th to 15th March in London, UK. This event, Europe's leading platform for biologics discovery and development, promises to be a pivotal gathering for industry experts and thought leaders.

The Antibody Therapeutics Xchange 2024, set to take place in San Diego on February 26th, is a highly anticipated event in the world of antibody therapeutics, and Biointron is proud to be a part of it.

Biointron has developed our own CHOK1-Fut8KO expression platform for afucosylated antibodies.